ViiV HEALTHCARE IS THE ONLY PHARMACEUTICAL COMPANY SOLELY FOCUSED ON PREVENTING, TREATING, AND ULTIMATELY, CURING HIV AND AIDS.
Our scientists and researchers are dedicated to discovering innovative new approaches to improve outcomes for people living with HIV, as well for those with reasons to prevent HIV. Here you’ll find stories about ViiV’s commitment to innovation through our science.
OUR SCIENCE
With modern advancements in HIV medicines and care, people living with HIV can live as long as people without HIV. But unfortunately, HIV stigma is still prevalent. That’s why we are using virtual reality to put healthcare professionals in the shoes of people living with HIV.
OUR SCIENCE
Explore the critical role of diversity in HIV clinical trials and how it shapes medical advancements, patient representation, and health equity. Learn from experts at ViiV Healthcare.
OUR SCIENCE
It is now established that if you’re on treatment and have an undetectable viral load, you cannot pass on HIV through sex. Undetectable = Untransmittable, or U=U. This simple equation has profound implications for everyone living with HIV, and for economies and governments around the world.
OUR SCIENCE
Why are we leaders in HIV innovation? Because we listen. We collect insights from people living with HIV around the world that informs our approach to the discovery and development of innovative new treatment and prevention options.
OUR SCIENCE
After spending a week at AIDS 2022, the world’s largest global health conference on HIV and AIDS, I’ve been thinking about the most wonderful trend we’re seeing in the field. There are fewer new cases of HIV each year, and people living with HIV are living longer.
OUR SCIENCE
Despite major advances in HIV treatment and prevention, there are still many unanswered questions that we need to address. For example, more research is needed to better understand whether some people living with HIV are prone to early development of certain diseases, and tend to age faster than people without HIV.
